Oral administration to SCD mice of the TRPV1 agonist, capsaicin, which activates somatosensory nerves through TRPV1 binding, was shown to dramatically alleviate acute vaso‐occlusive events and to significantly reduce ensuing chronic liver and kidney damage.4 This evidence concerns the gene TRPV1 and medical procedure.